Self-Sampling Strategy to Encourage Screening for High-Risk Human Papillomavirus
Women who used a self-screening assay for high-risk human papillomavirus had similar test results to those who were screened by a clinician.
Cervical Cancer
HPV Screening Associated With Reduced Remaining Lifetime Cervical Cancer Risk in Older Women
Researchers determined that women ≥55 years of age who underwent a single HPV DNA test with a negative diagnosis as well as routine cytology were found to be at low risk for cervical cancer.
Positive HPV Status Tied to Better Cervical Cancer Prognosis
Women with high-risk human papillomavirus-positive cervical tumors have a substantially better prognosis than women with hrHPV-negative tumors.
HPV Vaccination Decreases High-Grade Cervical Lesions in Women
From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.
USPSTF Updates Guidance for Cervical Cancer Screening
Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.
HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis
Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing
Good Evidence That HPV Vaccines Protect Against Cervical Precancer
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
Cervical cancer screening: recommendations from the USPSTF
The major change includes screening with hrHPV testing alone as an alternative to cytology screening alone starting at age 30 years.
Identifying cervical lesions
One clinician took issue with the image published in a January 2016 Clinical Advisor article.
HPV education key in college populations
College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission
Next post in AAPA 2016 Annual Meeting
